Prof.Dr. NİLGÜN SAYINALP

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major

FEDAİ A. B., KARAKULAK U. N., Aladag E., SAYINALP N.

Cardiovascular Toxicology , cilt.24, sa.1, ss.41-48, 2024 (SCI-Expanded)

Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives

AR M. C., El Fakih R., Gabbassova S., Alhuraiji A., Nasr F., Alsaeed A., et al.

Leukemia Research , cilt.133, 2023 (SCI-Expanded)

A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded)

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded)

Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded)

Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded)

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded)

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.

Transfusion and Apheresis Science , cilt.59, sa.5, 2020 (SCI-Expanded)

Indications and outcomes of splenectomy for hematological disorders

Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE , cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded)

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Chanan-Khan A., Cramer P., Demirkan F., Fraser G., Silva R. S., Grosicki S., et al.

LANCET ONCOLOGY , cilt.17, sa.2, ss.200-211, 2016 (SCI-Expanded)

The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded)

Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia

ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.

HEMATOLOGY , cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded)

Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromes.

Bektas O., Uner A., Buyukasik Y., Uz B., Bozkurt S., Eliacik E., et al.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , cilt.123, ss.445-51, 2015 (SCI-Expanded)

Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded)

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded)

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.

ACTA HAEMATOLOGICA , cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded)

The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded)

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded)

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Increased Soluble Selectins as a Reflection of Activated Platelets and Endothelium in Legg-Calve-Perthes Disease

Ismayilov V., Aksoy D. Y., SAYINALP N., Haznedarog I. C., AKSOY M. C.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.36, sa.7, 2014 (SCI-Expanded)

Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded)

An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded)

Clinical Perspectives About the Molecular Management of B-Lymphoproliferative Neoplasms

HAZNEDAROĞLU İ. C., SAYINALP N.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.1-3, 2014 (SCI-Expanded)

Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded)

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded)

EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.

HEMATOLOGY , cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded)

Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis

Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded)

Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded)

Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis

Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded)

Nasal Natural Killer/T-cell Lymphoma with Skin, Eye, and Peroneal Nerve Involvement

Turker B., Uz B., Isik M., BEKTAŞ Ö., DEMİROĞLU H., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.29, sa.4, ss.413-419, 2012 (SCI-Expanded)

Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL

Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded)

Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML

AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded)

Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria

GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.3, ss.223-227, 2011 (SCI-Expanded)

A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia

Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.20, sa.4, ss.341-344, 2011 (SCI-Expanded)

Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES , cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded)

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

LEUKEMIA RESEARCH , cilt.34, sa.12, 2010 (SCI-Expanded)

Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded)

Spinal Myeloid Sarcoma in Two Non-Leukemic Patients

Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

INTERNAL MEDICINE , cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded)

Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.

MEDICAL ONCOLOGY , cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded)

The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded)

Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

ANNALS OF HEMATOLOGY , cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded)

Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.101, sa.4, ss.370-372, 2009 (SCI-Expanded)

The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey

Ozatli D., GÖKER H., Buyuhasik Y., Sayinalp N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.29, sa.2, ss.388-394, 2009 (SCI-Expanded)

Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.101, sa.3, ss.270-272, 2009 (SCI-Expanded)

Thrombomodulin and GFC levels in Legg-Calve-Perthes disease

AKSOY M. C., Aksoy D. Y., HAZNEDAROĞLU İ. C., Sayinalp N., Kirazli S., Alpaslan M.

HEMATOLOGY , cilt.13, sa.6, ss.324-328, 2008 (SCI-Expanded)

Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients

BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.19, sa.7, ss.633-637, 2008 (SCI-Expanded)

Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.

ANNALS OF HEMATOLOGY , cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded)

Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts

Koca E., BÜYÜKAŞIK Y., Cetiner D., Yimaz R., Sayinalp N., Yasavul U., et al.

LEUKEMIA RESEARCH , cilt.32, sa.3, ss.495-499, 2008 (SCI-Expanded)

Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded)

Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease

Koca E., Haznedaroglu I. C., ÜNER A., Sayinalp N., Saglam A. E., Goker H., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.99, sa.11, ss.1243-1246, 2007 (SCI-Expanded)

Renin-angiotensin system expression in the K562 human erythroleukaemic cell line

Koca E., Haznedaroglu I. C., Acar K., Beyazit Y., Aksu S., Misirlioglu M., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.8, sa.3, ss.145-147, 2007 (SCI-Expanded)

Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia

Koca E., Sevimli F., Cetiner D., Haznedaroglu I. C., Sayinalp N., Buyukasik Y., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.82, sa.4, ss.333, 2007 (SCI-Expanded)

Stenotrophomonas maltophilia infection of the central venous catheter and lysis of an old thrombosis in a post-bone marrow transplantation child: Implications in the fibrinolytic process

Uckan D., Kirazli S., Gur D., Tavil B., Sayinalp N., Akyuz C.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , cilt.39, sa.4, ss.376-379, 2007 (SCI-Expanded)

Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia

Beyazit Y., Aksu S., Haznedaroglu I. C., Kekilli M., Misirlioglu M., Tuncer S., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.99, sa.1, ss.57-63, 2007 (SCI-Expanded)

Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML

Aksu S., Beyazit Y., Haznedaroglu I. C., Canpinar H., Kekilli M., ÜNER A., et al.

LEUKEMIA & LYMPHOMA , cilt.47, sa.5, ss.891-896, 2006 (SCI-Expanded)

Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation

Aksu S., Beyazit Y., Haznedaroglu I., Goker H., Kekilli M., Karakaya J., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.17, sa.1, ss.47-51, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia Rubra vera

Aksu S., Beyazit Y., Hazneidaroglu I., Kekilli M., Canpinar H., Misirlioglu M., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.33, sa.6, ss.661-667, 2005 (SCI-Expanded)

Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease

Cemalettin M., Aksoy D., Haznedaroglu I., Sayinalp N., Kirazli S., Alpaslan M.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.22, sa.5, ss.391-399, 2005 (SCI-Expanded)

Local umbilical cord blood renin-angiotensin system

Goker H., Haznedaroglu I., Beyazit Y., Aksu S., Tuncer S., Misirlioglu M., et al.

ANNALS OF HEMATOLOGY , cilt.84, sa.5, ss.277-281, 2005 (SCI-Expanded)

Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia

GÖNEN C., Haznedaroglu I., Aksu S., Koca E., Goker H., Buyukasik Y., et al.

PLATELETS , cilt.16, sa.1, ss.31-37, 2005 (SCI-Expanded)

Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders

Sayinalp N., Cinar H., ÜNER A., Haznedaroglu I., Buyukasik Y., Goker H., et al.

CLINICAL AND LABORATORY HAEMATOLOGY , cilt.26, sa.4, ss.265-268, 2004 (SCI-Expanded)

The predictability of factor V Leiden (FV : Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance

Sayinalp N., Haznedaroglu I., Aksu S., Buyukasik Y., Goker H., Parlak H., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.10, sa.3, ss.265-270, 2004 (SCI-Expanded)

Protein C inhibitor and serum amyloid A in immune thrombocytopaenic purpura

Sayinalp N., Haznedaroglu I., Buyukasik Y., Goker H., Aksu S., Kocoglu H., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.32, sa.1, ss.62-65, 2004 (SCI-Expanded)

Bone marrow and peripheral blood c-kit ligand concentrations in patients with thrombocytosis and thrombocytopenia

Asik M., Haznedaroglu I., Karakus S., Aksu S., Kocoglu H., Buyukasik Y., et al.

EXPERIMENTAL HEMATOLOGY , cilt.30, sa.6, ss.102, 2002 (SCI-Expanded)

Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease

Buyukasik Y., Karakus S., Goker H., Haznedaroglu I., Ozatli D., Sayinalp N., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.13, sa.4, ss.349-353, 2002 (SCI-Expanded)

Piebaldism associated with congenital dyserythropoietic anemia type II (HEMPAS)

Koklu S., Ertugrul D., Onat A., Karakus S., Haznedaroglu I., Buyukasik Y., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.69, sa.3, ss.210-213, 2002 (SCI-Expanded)

Plasma thrombospondin in immune thrombocytopenic purpura

Ozcebe O., Karakus S., Haznedaroglu I., Goker H., Kosar A., Kocoglu H., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.30, sa.1, ss.52-55, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

Plasma thrombopoietin in patients with cavernous transformation of the portal vein

Goker H., Egesel T., Karakus S., Haznedaroglu I., Apras S., Buyukasik Y., et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.75, sa.1, ss.91-94, 2002 (SCI-Expanded)

Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behcet's disease: evidence of a prethrombotic state

Ozatli D., Sayinalp N., Buyukasik Y., Karakus S., Haznedaroglu I., Kirazli S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.21, sa.4, ss.137-140, 2002 (SCI-Expanded)

Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis

Gurgey A., Haznedaroglu I., Egesel T., Buyukasik Y., Ozcebe O., Sayinalp N., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.67, sa.2, ss.107-111, 2001 (SCI-Expanded)

The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis

Birdane A., Haznedaroglu I., Ozath D., Sayinalp N., Kosar A., Buyukasik Y., et al.

EXPERIMENTAL HEMATOLOGY , cilt.28, sa.7, ss.120, 2000 (SCI-Expanded)

Beta-thalassemia intermedia associated with homozygosity for the -87 (C-->T) mutation in a Turkish family.

Gumruk F., Mergen H., Oner R., Ozcebe O., Sayinalp N., Oner C., et al.

Hemoglobin , cilt.24, sa.1, ss.23-9, 2000 (SCI-Expanded)

Lumiaggregometry can be used for estimation of platelet functions in patients with thrombocytopenia.

Buyukasik Y., Ozatli D., Sayinalp N., Haznedaroglu I., Kirazli S., Ozcebe O., et al.

BLOOD , cilt.94, sa.10, 1999 (SCI-Expanded)

Reduced platelet volume in microalbuminuric diabetic patients.

Sayinalp S., Sayinalp N.

BLOOD , cilt.94, sa.10, 1999 (SCI-Expanded)

Evaluation of the haemostatic system during ketoacidotic deterioration of diabetes mellitus

Ileri N., Buyukasik Y., Karaahmetoglu S., Ozatli D., Sayinalp N., Ozcebe O., et al.

HAEMOSTASIS , cilt.29, sa.6, ss.318-325, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

Effects of interferon-alpha 2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha 2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behcet's disease

Kosar A., Haznedaroglu S., Karaaslan Y., Buyukasik Y., Haznedaroglu I., Ozath D., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.19, ss.11-14, 1999 (SCI-Expanded)

Thrombosis and hemorrhage in chronic myeloproliferative disorders.

Bas B., Koksal A., Ozatli D., Haznedaroglu I., Buyukasik Y., Kosar A., et al.

BLOOD , cilt.94, sa.10, 1999 (SCI-Expanded)

Paget-Schroetter syndrome associated with FV:Q506 and prothrombin 20210A - A case report

Sayinalp N., Ozcebe O., Kirazli S., Dogan R., Dundar S., Gurgey A.

Angiology , cilt.50, sa.8, ss.689-692, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

Risk factors in central retinal vein occlusion and activated protein C resistance

Guven D., Sayinalp N., Kalayci D., Dundar S., Hasiripi H.

EUROPEAN JOURNAL OF OPHTHALMOLOGY , cilt.9, sa.1, ss.43-48, 1999 (SCI-Expanded)

Paget-Schroetter syndrome in a patient with Factor V Leiden

Sayinalp N., Ozcebe O., Buyukasik Y., Kosar Y., Gurgey A., Dogan R., et al.

BRITISH JOURNAL OF HAEMATOLOGY , cilt.102, sa.1, ss.252, 1998 (SCI-Expanded)

Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients

Sayinalp N., Erdem Y., Ozcebe O., Buyukasik Y., Caglar S., Dundar S.

THROMBOSIS RESEARCH , cilt.90, sa.4, ss.195-198, 1998 (SCI-Expanded)

Perianal infections in patients with leukemia - Importance of the course of neutrophil count

Buyukasik Y., Ozcebe O., Sayinalp N., Haznedaroglu I., Altundag O., Ozdemir O., et al.

DISEASES OF THE COLON & RECTUM , cilt.41, sa.1, ss.81-85, 1998 (SCI-Expanded)

Penile gangrene in lung cancer - Bronchiolo-alveolar carcinoma, disseminated intravascular coagulation, and nonbacterial thrombotic endocarditis.

Buyukasik Y., Sayinalp N., Arici M., Haznedaroglu I., Ozcebe O., Dundar S.

POSTGRADUATE MEDICAL JOURNAL , cilt.73, sa.863, ss.589-590, 1997 (SCI-Expanded)

Neutropenic enterocolitis in adult leukemias

Buyukasik Y., Ozcebe O., Haznedaroglu I., Sayinalp N., Soylu A., Ozdemir O., et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.66, sa.1, ss.47-55, 1997 (SCI-Expanded)

Plasma fibrinogen and coagulation inhibitors in nondiabetic offspring of patients with NIDDM.

Sayinalp S., Bayraktar M., Sayinalp N., Ozdemir O., Ozcebe O., Haznedaroglu I., et al.

BLOOD , cilt.88, sa.10, ss.3037, 1996 (SCI-Expanded)

Fibrinolytic system in plasma and pleural fluid in malignant pleural mesothelioma

Ozdemir O., Emri S., Karakoca Y., Sayinalp N., Akay H., Dundar S., et al.

THROMBOSIS RESEARCH , cilt.84, sa.2, ss.121-128, 1996 (SCI-Expanded)

Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity

Gursoy M., Haznedaroglu I., Celik I., Sayinalp N., Ozcebe O., Dundar S.

ANNALS OF PHARMACOTHERAPY , cilt.30, ss.762-765, 1996 (SCI-Expanded)

Circulating thrombomodulin as a molecular marker of endothelium damage in renal transplant recipients

Haznedaroglu I., Erdem Y., Yalcin A., Sayinalp N., Yasavul U., Turgan C., et al.

NEPHRON , cilt.73, sa.3, ss.486-487, 1996 (SCI-Expanded)

Local fibrinolysis in native arteriovenous fistulas of haemodialysis patients

Haznedaroglu I., Erdem Y., Celik I., Sayinalp N., Dundar S., Caglar S., et al.

BLOOD PURIFICATION , cilt.14, sa.3, ss.227-233, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma

Serum immunoglobulin E and soluble CD23 in patients with Graves' disease

Sayinalp S., Akalin S., Sayinalp N., Erbas T., Bayraktar M., Ozcebe O., et al.

HORMONE AND METABOLIC RESEARCH , cilt.28, sa.3, ss.133-137, 1996 (SCI-Expanded)

Cytokines in Behçet's disease.

Sayinalp N., Ozcebe O. I., Ozdemir O., Haznedaroğlu I. C., Dündar S., Kirazli S.

The Journal of rheumatology , cilt.23, ss.321-2, 1996 (SCI-Expanded)

Cytokines in Behcet's disease

Sayinalp N., Ozcebe O., Ozdemir O., Haznedaroglu I., Dundar S., Kirazli S.

JOURNAL OF RHEUMATOLOGY , cilt.23, sa.2, ss.321-322, 1996 (SCI-Expanded)

Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia

Haznedaroglu I., Ertenli I., Ozcebe O., Kiraz S., Ozdemir O., Sayinalp N., et al.

ACTA HAEMATOLOGICA , cilt.95, sa.2, ss.107-111, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma

Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis

Sayinalp N., Erdem Y., Haznedaroglu I., Dundar S., Caglar S., Kirazli S.

CLINICAL NEPHROLOGY , cilt.44, sa.6, ss.404, 1995 (SCI-Expanded)

BLOOD COLLECTION IN STRONG ACIDIC CITRATE ANTICOAGULANT FOR THE DETERMINATION OF UROKINASE-LIKE PLASMINOGEN ACTIVATOR

OZDEMIR O., HAZNEDAROGLU I., SAYINALP N., OZCEBE O., DUNDAR S., KIRAZLI S.

THROMBOSIS RESEARCH , cilt.80, sa.2, ss.189-191, 1995 (SCI-Expanded)

MEGAKARYOCYTOPOIETIC CYTOKINES IN AUTOIMMUNE THROMBOCYTOPENIC PURPURA

HAZNEDAROGLU I., SAYINALP N., OZCEBE O., OZDEMIR O., DUNDAR S., KIRAZLI S.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.49, sa.3, ss.265, 1995 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

The effect of prognostic features of patients with chronic lymphocytic leukemia on overall survival and treatment-free survival: A single-center experience

Alayvaz Aslan N., BÜYÜKAŞIK Y., SAYINALP N.

Journal of Experimental and Clinical Medicine (Turkey) , cilt.41, sa.1, ss.125-131, 2024 (Scopus)

History Of The Hematology Proficiency Exam And The Turkish Experience

BULDUK T., Demir A. M., Andic N., Sayınalp N., aylı m.

STED/Sürekli Tıp Eğitimi Dergisi , cilt.32, sa.4, ss.281-291, 2023 (Hakemli Dergi)

Endocrine Disorders in Adult Beta-Thalassemia Patients: Insights from a Long-Term Follow-Up

Oğuz S. H., OKAY M., FEDAİ A. B., ÜNAL Ş., GÜMRÜK F., SAYINALP N., et al.

Endocrinology Research and Practice , cilt.27, sa.4, ss.205-212, 2023 (Scopus)

THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.74, sa.1, ss.7-12, 2011 (ESCI)

DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.73, sa.3, ss.74-79, 2010 (ESCI)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia

TÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.373-374

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124

Metrikler

Yayın

189

Atıf (WoS)

1313

H-İndeks (WoS)

Atıf (Scopus)

1505

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Diğer Dergilerde Yayınlanan Makaleler

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Metrikler

Yayın

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim